BioStem Technologies Reports Q3 2026 Revenue of $7.6 Million, GAAP EPS Loss of $0. ...
Hospital Revenue Grows Sequentially While Margin Pressure and Cash Burn Weigh on Results Related Stocks: BSEM ,
Hospital Revenue Grows Sequentially While Margin Pressure and Cash Burn Weigh on Results Related Stocks: BSEM ,